FDA approved Protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught)
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
Tags:
Source: U.S. Centers for Disease Control and Prevention
Credit:
